Indian Manufacturer Nosch Labs Hit With 483 for Not Rejecting APIs

Drug Industry Daily
A A
Nosch Labs, a maker of active pharmaceutical ingredients, was hit with a five-observation FDA Form 483 after workers at its Veliminedu Village, Chityal Madal, India, facility were observed passing off APIs that failed to meet quality control standards.

To View This Article:

Login

Subscribe To Drug Industry Daily